Chinese herbal preparation for treating rectum carcinoma and preparation method thereof

Abstract

The invention relates to a Chinese herbal preparation for treating rectum carcinoma. The preparation comprises the following active pharmaceutical ingredients in parts by weight: 8.95-9.05 parts of cordyceps, 0.03-0.08 part of venenum bufonis, 14.95-15.05 parts of sophora flavescens, 9.95-10.5 parts of pseudobulbus cremastrae seu pleiones, 1.05-2.05 parts of brucea javanica, 11.05-12.05 parts of lithospermum purpurocaeruleum, 49.95-50.05 parts of hedyotis diffusa, 49.95-50.05 parts of scutellaria barbata, 19.95-20.05 parts of golden cypress, 0.25-0.35 part of realgar, 17.95-18.05 parts of mirabilite and 14.95-15.05 parts of liquorice. The Chinese herbal preparation is reasonable in formula, and moreover, the compatible Chinese herbal preparation does not have toxic and side effects, can gradually separate cancer tissues from rectum walls and discharge the cancer tissues out of the body, is simple in preparation method and low in production cost and has an obvious curative effect than conventional curative medicines; the Chinese herbal preparation has a wide treatment application scope, and can be used for treating patients with middle and later periods of cancer, advanced age, weakness or other diseases; and the Chinese herbal preparation has a good treatment effect and a high curative rate, and the survival rate of the operation patients after five years is 50%, and the survival rate of the patients after being treated by the Chinese herbal preparation in five years reaches above 70%.

Description

technical field [0001] The invention relates to a Chinese herbal medicine preparation and a preparation method, in particular to a Chinese herbal medicine preparation and a preparation method for treating rectal cancer. Background technique [0002] With the improvement of the quality of life, the incidence of rectal cancer is increasing year by year, which is formed by the malignant transformation of rectal tissue cells. Rectal cancer is a relatively refractory disease among malignant tumors with high morbidity and mortality. The current treatment methods are still based on traditional surgery, radiotherapy and chemotherapy. [0003] Surgical indications are narrow. Most rectal cancer patients are diagnosed at an advanced stage and have lost the opportunity for surgery. In addition, advanced age and other diseases are also taboos for surgery. Furthermore, after the operation, the patient left a fecal bag in the abdomen to replace the defecation of the anus, which brought a...

AI Technical Summary

Problems solved by technology

Furthermore, after the operation, the patient left a fecal bag in the abdomen to replace the anal defecation, which brought a lot of inconvenience to the patient's life.

With the combined treatment of surgery and chemotherapy, the 5-year survival rate of patients is less than 50%; with chemotherapy alone, the 5-year survival rate of patients is even lower